Christopher J. Kirk

Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

Susan D. Demo, Christopher J. Kirk, Monette Aujay et al. · Cancer Research · 2007 · 668 citations · Full text

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

Tony Muchamuel, Michael Basler, Monette Aujay et al. · Nature Medicine · 2009 · 590 citations

Inflammation, Rheumatology, Cytokine +12

Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity

E.M. Huber, Michael Basler, Ricarda Schwab et al. · Cell · 2012 · 488 citations · Full text

Protein Function, Protein Assembly, Biochemistry +9

Hormonal Stimulation of Phosphatidylinositol Breakdown, with Particular Reference to the Hepatic Effects of Vasopressin

Robert H. Michell, Christopher J. Kirk, M. M. BILLAH · Biochemical Society Transactions · 1979 · 435 citations

Hepatic Effects, October 1979, Hormonal Stimulation +23

Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events

Shirin Arastu‐Kapur, Janet L. Anderl, Marianne Kraus et al. · Clinical Cancer Research · 2011 · 405 citations